Erratum: Re: Abkhezr M and Dryer SE (2014) Angiotensin II and Canonical Transient Receptor Potential-6 Activation Stimulate Release of a Signal Transducer and Activator of Transcription 3-Activating Factor from Mouse Podocytes Mol Pharmacol August 2014 86:150-158; doi:10.1124/mol.114.092536;Angiotensin II and canonical transient receptor potential-6 activation stimulate release of a signal transducer and activator of transcription 3-activating factor from mouse podocytes

Molecular Pharmacology

Volumn 86, Issue 2, 2014, Pages 150-158

  Abkhezr, Mousa ^a   Dryer, Stuart E ^a,b  

^a University of Houston   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 OLEOYL 2 ACETYL SN GLYCEROL; ANGIOTENSIN II; DIACYLGLYCEROL DERIVATIVE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; SERINE; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CYTOKINE RELEASE; ENZYME ACTIVATION; EXPOSURE; GENETIC TRANSFECTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANGIOTENSIN II; ANIMALS; CALCINEURIN; CALCIUM; CELLS, CULTURED; MICE; PHOSPHORYLATION; PODOCYTES; PROTEIN KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRPC CATION CHANNELS;

EID: 84903593069     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.092536retraction     Document Type: Erratum

References (62)

1. Aaronson DS and Horvath CM (2002) A road map for those who don't know JAK-STAT. Science 296:1653-1655. (Pubitemid 34579157)
2. Aki K, Shimizu A, Masuda Y, Kuwahara N, Arai T, Ishikawa A, Fujita E, Mii A, Natori Y, and Fukunaga Y et al. (2010) ANG II receptor blockade enhances antiinflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol 298:F870-F882.
3. Anderson M, Kim EY, Hagmann H, Benzing T, and Dryer SE (2013) Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol. Am J Physiol Cell Physiol 305:C276-C289.
4. Anderson M, Roshanravan H, Khine J, and Dryer SE (2014) Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species. J Cell Physiol 229:434-442.
5. Arakawa T, Masaki T, Hirai T, Doi S, Kuratsune M, Arihiro K, Kohno N, and Yorioka N (2008) Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis. Nephrol Dial Transplant 23:3418-3426.
6. Bariéty J, Nochy D, Mandet C, Jacquot C, Glotz D, and Meyrier A (1998) Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 53:918-925. (Pubitemid 28155664)
7. Barisoni L, Kriz W, Mundel P, and D'Agati V (1999) The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10:51-61. (Pubitemid 29034942)
8. Bost KL and Mason MJ (1995) Thapsigargin and cyclopiazonic acid initiate rapid and dramatic increases of IL-6 mRNA expression and IL-6 secretion in murine peritoneal macrophages. J Immunol 155:285-296.
9. Brenner BM (1978) Adaptation of glomerular forces and flows to renal injury. Yale J Biol Med 51:301-305.
10. Dai Y, Gu L, Yuan W, Yu Q, Ni Z, Ross MJ, Kaufman L, Xiong H, Salant DJ, and He JC et al. (2013) Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis. Kidney Int 84:950-961.
11. Darnell JE, Jr, Kerr IM, and Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421. (Pubitemid 24217131)
12. Darnell JE, Jr (1997) STATs and gene regulation. Science 277:1630-1635.
13. Dryer SE and Reiser J (2010) TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol 299:F689-F701.
14. Eckel J, Lavin PJ, Finch EA, Mukerji N, Burch J, Gbadegesin R, Wu G, Bowling B, Byrd A, Hall G, Sparks M, Zhang ZS, Homstad A, Barisoni L, Birnbaumer L, Rosenberg P, and Winn MP (2011) TRPC6 enhances angiotensin II-evoked albuminuria. J Am Soc Nephrol 22:526-535.
15. Endlich N and Endlich K (2006) Stretch, tension and adhesion - adaptive mechanisms of the actin cytoskeleton in podocytes. Eur J Cell Biol 85:229-234.
16. Feng X, Lu TC, Chuang PY, Fang W, Ratnam K, Xiong H, Ouyang X, Shen Y, Levy DE, and Hyink D et al. (2009) Reduction of Stat3 activity attenuates HIV-induced kidney injury. J Am Soc Nephrol 20:2138-2146.
17. Fitzgerald JS, Poehlmann TG, Schleussner E, and Markert UR (2008) Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum Reprod Update 14:335-344. (Pubitemid 351858973)
18. Fornoni A, Ijaz A, Tejada T, and Lenz O (2008) Role of inflammation in diabetic nephropathy. Curr Diabetes Rev 4:10-17. (Pubitemid 351216880)
19. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, and Hirano T (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5:449-460. (Pubitemid 26423473)
20. Gu L, Dai Y, Xu J, Mallipattu S, Kaufman L, Klotman PE, He JC, and Chuang PY (2013) Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS 27:1091-1098.
21. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, Iyengar R, and Klotman PE (2004) Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114:643-651. (Pubitemid 39578754)
22. Hiramatsu N, Hiromura K, Shigehara T, Kuroiwa T, Ideura H, Sakurai N, Takeuchi S, Tomioka M, Ikeuchi H, and Kaneko Y et al. (2007) Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model. J Am Soc Nephrol 18:515-527. (Pubitemid 46193317)
23. Ideura H, Hiromura K, Hiramatsu N, Shigehara T, Takeuchi S, Tomioka M, Sakairi T, Yamashita S, Maeshima A, and Kaneko Y et al. (2007) Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. Am J Physiol Renal Physiol 293:F1214-F1221. (Pubitemid 47583955)
24. Kim DI and Park SH (2013) Sequential signaling cascade of IL-6 and PGC-1α is involved in high glucose-induced podocyte loss and growth arrest. Biochem Biophys Res Commun 435:702-707.
25. Ca trafficking to the surface of cultured podocytes. Mol Pharmacol 75:466-477.
26. + channel isoform and regulates its expression on the cell surface. Am J Physiol Renal Physiol 295:F235-F246.
27. Kim EY, Anderson M, and Dryer SE (2012a) Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species. Am J Physiol Renal Physiol 302:F298-F307.
28. Kim EY, Anderson M, and Dryer SE (2012b) Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death. Mol Pharmacol 82:728-737.
29. Kim EY, Anderson M, Wilson C, Hagmann H, Benzing T, and Dryer SE (2013) NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex. Am J Physiol Cell Physiol 305:C960-C971.
30. Kinoshita Y, Kondo S, Urushihara M, Suga K, Matsuura S, Takamatsu M, Shimizu M, Nishiyama A, Kawachi H, and Kagami S (2011) Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis. Transl Res 158:235-248.
31. Korgaonkar SN, Feng X, Ross MD, Lu TC, D'Agati V, Iyengar R, Klotman PE, and He JC (2008) HIV-1 upregulates VEGF in podocytes. J Am Soc Nephrol 19:877-883.
32. Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, Carpio JD, Ruiz P, Mezzano SA, Li J, and Wei C et al. (2010) Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS ONE 5:e12859.
33. 2+ -dependent production and release of IL-8 in human neutrophils. J Immunol 161:4332-4339.
34. Lee SJ, Borsting E, Declèves AE, Singh P, and Cunard R (2012) Podocytes express IL-6 and lipocalin 2/ neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury. Nephron, Exp Nephrol 121:e86-e96.
35. Le Gall SM, Bobé P, Reiss K, Horiuchi K, Niu XD, Lundell D, Gibb DR, Conrad D, Saftig P, and Blobel CP (2009) ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol Biol Cell 20:1785-1794.
36. Liu BC, Song X, Lu XY, Li DT, Eaton DC, Shen BZ, Li XQ, and Ma HP (2013) High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. Biochim Biophys Acta 1833:1434-1442.
37. Maddox DA, Bennett CM, Deen WM, Glassock RJ, Knutson D, Daugharty TM, and Brenner BM (1975) Determinants of glomerular filtration in experimental glomerulonephritis in the rat. J Clin Invest 55:305-318.
38. Massagué J and Pandiella A (1993) Membrane-anchored growth factors. Annu Rev Biochem 62:515-541. (Pubitemid 23237880)
39. Matsui F and Meldrum KK (2012) The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease. J Surg Res 178:339-345.
40. Migliorini A, Angelotti ML, Mulay SR, Kulkarni OO, Demleitner J, Dietrich A, Sagrinati C, Ballerini L, Peired A, and Shankland SJ et al. (2013) The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol 183:431-440.
41. Mii A, Shimizu A, Masuda Y, Ishizaki M, Kawachi H, Iino Y, Katayama Y, and Fukuda Y (2009) Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression. Lab Invest 89:164-177.
42. Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, Pippin JW, Rastaldi MP, Wawersik S, and Schiavi S et al. (2007) Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 18:29-36. (Pubitemid 46053419)
43. Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, and Möller CC et al. (2011) Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol 179:1719-1732.
44. Rao S, Liu X, Freedman BD, and Behrens EM (2013) Spleen tyrosine kinase (Syk)-dependent calcium signals mediate efficient CpG-induced exocytosis of tumor necrosis factor α (TNFα) in innate immune cells. J Biol Chem 288:12448-12458.
45. Rastaldi MP, Armelloni S, Berra S, Calvaresi N, Corbelli A, Giardino LA, Li M, Wang GQ, Fornasieri A, and Villa A et al. (2006) Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J 20:976-978.
46. Rastaldi MP, Armelloni S, Berra S, Li M, Pesaresi M, Poczewski H, Langer B, Kerjaschki D, Henger A, and Blattner SM et al. (2003) Glomerular podocytes possess the synaptic vesicle molecule Rab3A and its specific effector rabphilin-3a. Am J Pathol 163:889-899. (Pubitemid 37040125)
47. Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, and Avila-Casado C et al. (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37:739-744. (Pubitemid 41754891)
48. Roshanravan H and Dryer SE (2014) ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species. Am J Physiol Renal Physiol 306:F1088-F1097.
49. Rüster C and Wolf G (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17:2985-2991. (Pubitemid 44707758)
50. Sanchez-Miranda E, Ibarra-Sanchez A, and Gonzalez-Espinosa C (2010) Fyn kinase controls FcepsilonRI receptor-operated calcium entry necessary for full degranulation in mast cells. Biochem Biophys Res Commun 391:1714-1720.
51. Sano M, Fukuda K, Kodama H, Takahashi T, Kato T, Hakuno D, Sato T, Manabe T, Tahara S, and Ogawa S (2000) Autocrine/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation. Biochem Biophys Res Commun 269:798-802. (Pubitemid 30440380)
52. Schindler C and Darnell JE, Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64:621-651.
53. Schlöndorff J, Del Camino D, Carrasquillo R, Lacey V, and Pollak MR (2009) TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am J Physiol Cell Physiol 296:C558-C569.
54. Schwimmer JA, Markowitz GS, Valeri A, and Appel GB (2003) Collapsing glomerulopathy. Semin Nephrol 23:209-218. (Pubitemid 36397103)
55. Skurk T, van Harmelen V, and Hauner H (2004) Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-κB. Arterioscler Thromb Vasc Biol 24:1199-1203. (Pubitemid 38880008)
56. Stow JL, Low PC, Offenhäuser C, and Sangermani D (2009) Cytokine secretion in macrophages and other cells: pathways and mediators. Immunobiology 214:601-612.
57. Suzuki Y, Shirato I, Okumura K, Ravetch JV, Takai T, Tomino Y, and Ra C (1998) Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int 54:1166-1174. (Pubitemid 28449903)
58. Taga T and Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819. (Pubitemid 27169299)
59. Tian D, Jacobo SM, Billing D, Rozkalne A, Gage SD, Anagnostou T, Pavenstädt H, Hsu HH, Schlondorff J, and Ramos A et al. (2010) Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci Signal 3:ra77.
60. Wegenka UM, Buschmann J, Lütticken C, Heinrich PC, and Horn F (1993) Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 13:276-288. (Pubitemid 23006905)
61. Yokogami K, Wakisaka S, Avruch J, and Reeves SA (2000) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 10:47-50. (Pubitemid 30057415)
62. Yu H, Pardoll D, and Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9:798-809.